CareCloud (CCLD) files Form 8-K furnishing Regulation FD press release

Rhea-AI Filing Summary

CareCloud, Inc. filed a Form 8-K to report that it issued a press release on November 10, 2025. The company furnished the release under Regulation FD as Exhibit 99.1, meaning it is provided for information purposes and is not treated as filed for liability purposes under the Exchange Act.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

false 0001582982 0001582982 2025-11-10 2025-11-10 0001582982 CCLD:CommonStockParValue0.001PerShareMember 2025-11-10 2025-11-10 0001582982 CCLD:Sec8.75SeriesBCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember 2025-11-10 2025-11-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 10, 2025

CareCloud, Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-36529		22-3832302
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

7 Clyde Road, Somerset, New Jersey 08873
(Address of principal executive offices, zip code)

(732) 873-5133

(Registrant’s telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.001 per share		CCLD		Nasdaq Global Market
8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share		CCLDO		Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure

On November 10, 2025, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information furnished pursuant to Item 7.01 of this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1	Press release dated November 10, 2025.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

2

SIGNATURE(S)

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	CareCloud, Inc.
Date: November 10, 2025	By:	/s/ Norman Roth
		Norman Roth
		Interim Chief Financial Officer and Corporate Controller

3

FAQ

What did CareCloud (CCLD) report in its November 10, 2025 Form 8-K?

CareCloud reported that it issued a press release on November 10, 2025. The release is furnished under Regulation FD as Exhibit 99.1, providing information to the market without being deemed filed under Section 18 of the Exchange Act.

What is the significance of Item 7.01 for CareCloud (CCLD) in this 8-K?

Item 7.01 indicates CareCloud furnished information under Regulation FD. This allows the company to share its November 10, 2025 press release broadly with investors while specifying that the information is not considered filed for certain Exchange Act liability purposes.

Which exhibits are included in CareCloud (CCLD) November 10, 2025 Form 8-K?

The Form 8-K includes Exhibit 99.1, a press release dated November 10, 2025, and Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document. These exhibits support electronic access and clarity for investors.

Who signed CareCloud’s (CCLD) November 10, 2025 Form 8-K?

The Form 8-K was signed on behalf of CareCloud by Norman Roth. He is identified as the Interim Chief Financial Officer and Corporate Controller, acting as the duly authorized officer as of November 10, 2025.

Are CareCloud’s (CCLD) common and preferred shares listed on Nasdaq?

Yes. The Form 8-K notes CareCloud’s common stock trades on the Nasdaq Global Market under ticker CCLD, and its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock trades under ticker CCLDO on the same market.